| Relation | Metric | Value | YoY |
|---|
Where did the money come from, and where was it spent?
Revenue and operating profit grew together, indicating healthy core operations.
The largest revenue segment accounts for 82.34% of revenue, indicating concentration.
- Revenue
- USD 105.38B YoY +7.72%
- Largest revenue segment share (North American Pharmaceutical)
- 82.34% YoY −2.22pp
- Cost of revenue
- USD 101.69B Share 96.50% · YoY +7.56%
- Selling, general and administrative
- USD 2.26B Share 2.15% · YoY +3.10%
View calculation evidence
YoY periods: Q1 2027 compared with Q1 2026
Source metrics
- Largest revenue segment share (North American Pharmaceutical)North American Pharmaceutical · segment_value / revenue * 100
- RevenueTotal revenues · RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenueCost of product and service sold · CostOfGoodsAndServicesSold
- Selling, general and administrativeSelling, general and administrative expense · SellingGeneralAndAdministrativeExpense